Medical Care Review: Specials Magazine
The journey to parenthood is one of life’s most meaningful transitions. For many, it’s a period of joy and anticipation. But for some, memories of the past bring uncertainty. They may have lost a child without knowing why, or are caring for children with special medical or developmental needs and live with the anxiety that the next pregnancy could have the same result. Others worry that genetic conditions may be passed on. In every situation, people seek answers they can trust. Minerva Clinic offers clarity and reassurance through its one-stop genetic and prenatal diagnostic services. It handles every stage of the journey, from preconception carrier screening to confirmatory diagnostics and result explanation, with full medical accountability. Tests are merely a door that opens to a wider path of care. Families are handheld from pre-test counseling to postnatal assistance to help them understand their options and what each outcome may mean for their lives. Reliable, consistent counsel enables them to make choices they can accept with true peace of mind. “My mission is not merely to detect genetic risks, but to accompany couples through uncertainty, offering scientific clarity and emotional support to move forward,” says Dr. Hiromi Nakata, director. Dr. Nakata spent her high school years as the only Japanese student in a small rural town in Belgium. Living among people of diverse cultures and beliefs taught her to respect individual values, a principle that continues to guide her philosophy of honoring every patient’s decision. Armed with national board certifications in clinical genetics, oncology and general internal medicine, she provides scientifically grounded services. In a society facing declining birthrates, her work has profound meaning.
Practitioner Insights
The Opioid Pandemic and Enhanced Recovery after Surgery: Eliminating Opioids from Routine Surgical Practice
Dr. Carlos Sandoval-Herrera, Director of Gynecology and Chief of the Division of Minimally Invasive Gynecology, Sinai Chicago
The Hidden Cardiovascular Threat Post-Pregnancy: A Call for Comprehensive Care
Dr. J. Krystal Ascencio, Acting Chairperson of the Department of Obstetrics and Gynecology, Jamaica Hospital
Team Leadership
Colin Baker, Director Medical Imaging and Pathology Contract, Western Health
Emerging Diagnostic Technologies in Healthcare
Winny Xie, Molecular Predictive & Diagnostic Lab Head, PT Prodia Widyahusada Tbk
Creating a Congenial Hospital Space
Janene Lawrence, Clinical Nurse Manager (Medical), Hutt Valley DHB
The Rosy App's Success in Cervical Cancer Education
Lyndsey Harper, Attending Physician- Obstetrics and Gynecology, Baylor Scott & White Health
Workforce Pipeline Securing New Zealand's Medical Future
Jonathan Albrett, Director of Clinical Training, Te Whatu Ora Taranaki
IN FOCUS
Fertility Treatment Evolution: Personalized Care Shapes APAC Centers
APAC fertility centers embrace advanced technologies, personalized care, and holistic support, improving treatment success, patient experience, and accessibility across the region.
APAC Prenatal Testing Landscape: Shifting Needs and Innovations
New prenatal testing service in APAC enhances early diagnostics through advanced technologies, improved accessibility, digital integration, and expanded opportunities that strengthen maternal and fetal care.
EDITORIAL
The Rise of a Connected Prenatal Testing Infrastructure
Prenatal screening has moved from biochemical markers to non-invasive genomic analysis of cell-free fetal DNA. These NIPT platforms offer high accuracy without procedural risk, giving clinicians earlier visibility into chromosomal conditions and expanding access for diverse pregnancy profiles. Improved sequencing and refined bioinformatics are further strengthening reliability.
Genetic diagnostics are progressing from targeted tests to comprehensive genomic evaluation. Next-generation sequencing, chromosomal microarrays and expanded carrier screening enable the earlier detection of inherited and rare disorders, bringing prenatal care closer to a comprehensive genetic picture. Growing datasets are now supported by machine-learning tools that assist interpretation and identify emerging patterns.
Service delivery is transforming as well. Digital platforms connect patients, clinicians and laboratories, supported by telehealth counselling, streamlined ordering and patient-friendly interfaces. Early use of AI-driven analysis is reducing turnaround times and improving reporting clarity.
Market momentum reflects this evolution. Prenatal testing services are projected to grow from about USD 27.76 billion by 2034, growing at a CAGR of 12.94 percent.
This edition Medical Care Review APAC, highlights leaders shaping the future of care. Jonathan Albrett outlines New Zealand’s developing medical training pipeline, emphasizing stronger educator networks, clearer pathways and the value of community-based experience. Carlos Sandoval-Herrera shows how enhanced recovery protocols can reduce opioid use and support safer surgical outcomes.
We also spotlight Minerva Clinic, which is redefining genetic and prenatal testing through its one-stop model. Its integrated pathway links carrier screening, advanced NIPT and in-house diagnostics, giving families a complete and accountable understanding of their genetic landscape. Guided by Dr. Hiromi Nakata, the clinic combines scientific precision with ongoing counselling to support patients through life-altering decisions.
We hope these insights provide a clearer understanding of how technology, clinical leadership and compassionate care are transforming the patient experience.
